351 related articles for article (PubMed ID: 12629346)
1. Multimodality management of urachal carcinoma: the M. D. Anderson Cancer Center experience.
Siefker-Radtke AO; Gee J; Shen Y; Wen S; Daliani D; Millikan RE; Pisters LL
J Urol; 2003 Apr; 169(4):1295-8. PubMed ID: 12629346
[TBL] [Abstract][Full Text] [Related]
2. [Clinical analysis of 14 cases of urachal carcinoma].
Chen ZF; Wang F; Qin ZK; Dai YP; Zhou FJ; Han H; Liu ZW; Yu SL; Li YH; Ye YL
Ai Zheng; 2008 Sep; 27(9):966-9. PubMed ID: 18799037
[TBL] [Abstract][Full Text] [Related]
3. Urachal carcinoma: a clinicopathologic analysis of 24 cases with outcome correlation.
Gopalan A; Sharp DS; Fine SW; Tickoo SK; Herr HW; Reuter VE; Olgac S
Am J Surg Pathol; 2009 May; 33(5):659-68. PubMed ID: 19252435
[TBL] [Abstract][Full Text] [Related]
4. Urachal carcinoma: surgical and chemotherapeutic options.
Siefker-Radtke A
Expert Rev Anticancer Ther; 2006 Dec; 6(12):1715-21. PubMed ID: 17181485
[TBL] [Abstract][Full Text] [Related]
5. Surgical and chemotherapeutic options for urachal carcinoma: report of ten cases and literature review.
Yazawa S; Kikuchi E; Takeda T; Matsumoto K; Miyajima A; Nakagawa K; Oya M
Urol Int; 2012; 88(2):209-14. PubMed ID: 22143067
[TBL] [Abstract][Full Text] [Related]
6. [A Case of Urachal Carcinoma Treated by TS-1/CDDP as Adjuvant Chemotherapy].
Inoue K; Shimada M; Saito K; Ogawa Y; Matsubara E; Matsumoto Y; Keiichiro H
Hinyokika Kiyo; 2015 Nov; 61(11):441-3. PubMed ID: 26699888
[TBL] [Abstract][Full Text] [Related]
7. Adenocarcinoma of bladder.
Dandekar NP; Dalal AV; Tongaonkar HB; Kamat MR
Eur J Surg Oncol; 1997 Apr; 23(2):157-60. PubMed ID: 9158192
[TBL] [Abstract][Full Text] [Related]
8. [A case of urachal carcinoma treated with S-1/CDDP combination chemotherapy].
Sekita N; Fujimura M; Arai H; Shibata N; Nishikawa R; Sugano I; Mikami K
Hinyokika Kiyo; 2010 Aug; 56(8):447-51. PubMed ID: 20808064
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
[TBL] [Abstract][Full Text] [Related]
10. Metastatic urachal cancer responding to FOLFOX chemotherapy.
Tran B; McKendrick J
Can J Urol; 2010 Apr; 17(2):5120-3. PubMed ID: 20398453
[TBL] [Abstract][Full Text] [Related]
11. Complete response of a recurrent advanced urachal carcinoma treated by S-1/cisplatin combination chemotherapy.
Kojima Y; Yamada Y; Kamisawa H; Sasaki S; Hayashi Y; Kohri K
Int J Urol; 2006 Aug; 13(8):1123-5. PubMed ID: 16903943
[TBL] [Abstract][Full Text] [Related]
12. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
[TBL] [Abstract][Full Text] [Related]
13. Laparoscopic partial cystectomy with en bloc resection of the urachus for urachal adenocarcinoma.
Hong SH; Kim JC; Hwang TK
Int J Urol; 2007 Oct; 14(10):963-5. PubMed ID: 17880303
[TBL] [Abstract][Full Text] [Related]
14. [Urachal carcinoma: experience of a clinical center within 30 years].
Shao GJ; Cai L; Li XS; Song G; Li XY; He ZS; Zhou LQ
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Oct; 45(5):774-8. PubMed ID: 24136277
[TBL] [Abstract][Full Text] [Related]
15. [Complete response to M-FAP chemotherapy for multiple lung metastases after segmental resection of urachal carcinoma : a case report].
Hongoh S; Nomoto T; Kawakami M; Hanai K; Inatsuchi H; Terachi T
Hinyokika Kiyo; 2010 Feb; 56(2):107-10. PubMed ID: 20185997
[TBL] [Abstract][Full Text] [Related]
16. The effect of cystectomy, and perioperative methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy on the risk and pattern of relapse in patients with muscle invasive bladder cancer.
Ennis RD; Petrylak DP; Singh P; Bagiella E; O'Toole KM; Benson MC; Olsson CA
J Urol; 2000 May; 163(5):1413-8. PubMed ID: 10751847
[TBL] [Abstract][Full Text] [Related]
17. Primary rectal carcinoma in patients with stage IV resectable disease at diagnosis.
Pasetto LM; Friso ML; Pucciarelli S; Basso U; Toppan P; Rugge M; Sinigaglia G; Nitti D; Sotti G; Monfardini S
Anticancer Res; 2007; 27(2):1079-85. PubMed ID: 17465247
[TBL] [Abstract][Full Text] [Related]
18. Anterior wall adenocarcinoma of bladder with similar clinicopathological and prognostic characteristics as common bladder carcinomas should not be treated as or classified into urachal adenocarcinomas.
Zhou YW; Long YX; Song K; Liang LB; Cheng K; Chen Y; Liu JY
Cancer Med; 2021 Aug; 10(16):5415-5428. PubMed ID: 34278741
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant chemotherapy for primary adenocarcinomas of the urinary bladder: a single-site experience.
Yu B; Zhou J; Cai H; Xu T; Xu Z; Zou Q; Gu M
BMC Urol; 2015 Jan; 15(1):3. PubMed ID: 25631709
[TBL] [Abstract][Full Text] [Related]
20. Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC.
Millikan R; Dinney C; Swanson D; Sweeney P; Ro JY; Smith TL; Williams D; Logothetis C
J Clin Oncol; 2001 Oct; 19(20):4005-13. PubMed ID: 11600601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
